Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 2006, p. 561-570, Vol. 44, No. 2
0095-1137/06/$08.00+0 doi:10.1128/JCM.44.2.561-570.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Departments of Urology,1 Medicine,2 Biomathematics,4 Human Genetics,5 Pathology and Laboratory Medicine,6 Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, California 90095,7 GeneFluidics Inc., Monterey Park, California 91754,3 Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California 900738
Received 28 July 2005/ Returned for modification 28 October 2005/ Accepted 13 November 2005
We describe the first species-specific detection of bacterial pathogens in human clinical fluid samples using a microfabricated electrochemical sensor array. Each of the 16 sensors in the array consisted of three single-layer gold electrodesworking, reference, and auxiliary. Each of the working electrodes contained one representative from a library of capture probes, each specific for a clinically relevant bacterial urinary pathogen. The library included probes for Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa, Enterocococcus spp., and the Klebsiella-Enterobacter group. A bacterial 16S rRNA target derived from single-step bacterial lysis was hybridized both to the biotin-modified capture probe on the sensor surface and to a second, fluorescein-modified detector probe. Detection of the target-probe hybrids was achieved through binding of a horseradish peroxidase (HRP)-conjugated anti-fluorescein antibody to the detector probe. Amperometric measurement of the catalyzed HRP reaction was obtained at a fixed potential of 200 mV between the working and reference electrodes. Species-specific detection of as few as 2,600 uropathogenic bacteria in culture, inoculated urine, and clinical urine samples was achieved within 45 min from the beginning of sample processing. In a feasibility study of this amperometric detection system using blinded clinical urine specimens, the sensor array had 100% sensitivity for direct detection of gram-negative bacteria without nucleic acid purification or amplification. Identification was demonstrated for 98% of gram-negative bacteria for which species-specific probes were available. When combined with a microfluidics-based sample preparation module, the integrated system could serve as a point-of-care device for rapid diagnosis of urinary tract infections.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|